117 related articles for article (PubMed ID: 25855954)
1. Transmembrane-4-L-six-family-1, a potential predictor for poor prognosis, overexpressed in human glioma.
Wang P; Bao W; Zhang G; Cui H; Shi G
Neuroreport; 2015 May; 26(8):455-61. PubMed ID: 25855954
[TBL] [Abstract][Full Text] [Related]
2. Forkhead-box A1 transcription factor is a novel adverse prognosis marker in human glioma.
Wang L; Qin H; Li L; Feng F; Ji P; Zhang J; Li G; Zhao Z; Gao G
J Clin Neurosci; 2013 May; 20(5):654-8. PubMed ID: 23510544
[TBL] [Abstract][Full Text] [Related]
3. Co-expression of midkine and pleiotrophin predicts poor survival in human glioma.
Ma J; Lang B; Wang X; Wang L; Dong Y; Hu H
J Clin Neurosci; 2014 Nov; 21(11):1885-90. PubMed ID: 25001988
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer.
Peng XC; Zeng Z; Huang YN; Deng YC; Fu GH
Cancer Med; 2018 Jun; 7(6):2592-2600. PubMed ID: 29665316
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human glioma.
Wang L; He S; Tu Y; Ji P; Zong J; Zhang J; Feng F; Zhao J; Gao G; Zhang Y
J Clin Neurosci; 2013 Jul; 20(7):958-63. PubMed ID: 23707602
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of NDRG2 is related to poor overall survival in patients with glioma.
Li W; Chu D; Chu X; Meng F; Wei D; Li H; Sun B
J Clin Neurosci; 2011 Nov; 18(11):1534-7. PubMed ID: 21872476
[TBL] [Abstract][Full Text] [Related]
7. FGF2 as a potential prognostic biomarker for proneural glioma patients.
Sooman L; Freyhult E; Jaiswal A; Navani S; Edqvist PH; Pontén F; Tchougounova E; Smits A; Elsir T; Gullbo J; Lennartsson J; Bergqvist M; Ekman S
Acta Oncol; 2015 Mar; 54(3):385-94. PubMed ID: 25263081
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
Lai NS; Dong QS; Ding H; Miao ZL; Lin YC
J Clin Neurosci; 2014 May; 21(5):755-60. PubMed ID: 24382515
[TBL] [Abstract][Full Text] [Related]
9. Somatic CPEB4 and CPEB1 genes mutations spectrum on the prognostic predictive accuracy in patients with high-grade glioma and their clinical significance.
Boustani MR; Mehrabi F; Yahaghi E; Khoshnood RJ; Shahmohammadi M; Darian EK; Goudarzi PK
J Neurol Sci; 2016 Apr; 363():80-3. PubMed ID: 27000226
[TBL] [Abstract][Full Text] [Related]
10. Predictive and prognostic value of TLR9 and NFKBIA gene expression as potential biomarkers for human glioma diagnosis.
Miyar A; Habibi I; Ebrahimi A; Mansourpour D; Mokarizadeh A; Rajabi A; Farshgar R; Eshaghzadeh M; Zamani-Ahmadmahmudi M; Nodushan SM
J Neurol Sci; 2016 Sep; 368():314-7. PubMed ID: 27538656
[TBL] [Abstract][Full Text] [Related]
11. Concomitant microRNA-31 downregulation and radixin upregulation predicts advanced tumor progression and unfavorable prognosis in patients with gliomas.
Wang S; Jiao B; Geng S; Song J; Liang Z; Lu S
J Neurol Sci; 2014 Mar; 338(1-2):71-6. PubMed ID: 24380686
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of Nedd4L is associated with the aggressive progression and worse prognosis of malignant glioma.
He S; Deng J; Li G; Wang B; Cao Y; Tu Y
Jpn J Clin Oncol; 2012 Mar; 42(3):196-201. PubMed ID: 22217575
[TBL] [Abstract][Full Text] [Related]
13. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
14. Low expression of insulin-like growth factor binding protein 7 associated with poor prognosis in human glioma.
Tian X; Zhang L; Sun L; Xue Y; Xie S
J Int Med Res; 2014 Jun; 42(3):651-8. PubMed ID: 24743871
[TBL] [Abstract][Full Text] [Related]
15. Over-expression of wild-type p53-induced phosphatase 1 confers poor prognosis of patients with gliomas.
Liang C; Guo E; Lu S; Wang S; Kang C; Chang L; Liu L; Zhang G; Wu Z; Zhao Z; Ma S; Wang L; Jiao BH
Brain Res; 2012 Mar; 1444():65-75. PubMed ID: 22325093
[TBL] [Abstract][Full Text] [Related]
16. Correlation of low SLC22A18 expression with poor prognosis in patients with glioma.
Chu SH; Ma YB; Feng DF; Zhang H; Zhu ZA; Li ZQ; Jiang PC
J Clin Neurosci; 2012 Jan; 19(1):95-8. PubMed ID: 22153794
[TBL] [Abstract][Full Text] [Related]
17. TM4SF1 promotes glioma malignancy through multiple mechanisms.
Zheng YW; Wang M; Zhong ZM; Wu GQ; Zhang T; Chen LL; Li M
Neoplasma; 2022 Jul; 69(4):859-867. PubMed ID: 35532297
[TBL] [Abstract][Full Text] [Related]
18. Correlation of expression levels of ANXA2, PGAM1, and CALR with glioma grade and prognosis.
Gao H; Yu B; Yan Y; Shen J; Zhao S; Zhu J; Qin W; Gao Y
J Neurosurg; 2013 Apr; 118(4):846-53. PubMed ID: 23082878
[TBL] [Abstract][Full Text] [Related]
19. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
[TBL] [Abstract][Full Text] [Related]
20. Identification of microRNA-205 as a potential prognostic indicator for human glioma.
Hou SX; Ding BJ; Li HZ; Wang L; Xia F; Du F; Liu LJ; Liu YH; Liu XD; Jia JF; Li L; Wu ZL; Zhao G; Zhang ZG; Deng YC
J Clin Neurosci; 2013 Jul; 20(7):933-7. PubMed ID: 23683741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]